Stock Track | Jazz Pharmaceuticals Soars 6.99% Intraday on Multiple Analyst Price Target Hikes

Stock Track
02/25

Jazz Pharmaceuticals PLC (JAZZ) saw its stock price soar 6.99% during intraday trading on Wednesday, reflecting significant investor optimism.

The sharp rise follows a series of positive analyst actions, with at least four major financial institutions raising their price targets for the company. Morgan Stanley increased its price target to $226 from $225, Wells Fargo lifted its target to $250 from $235, Deutsche Bank raised its target to $255 from $210, and Bofa Global Research boosted its price objective to $275 from $263.

These upward revisions reflect growing analyst confidence in Jazz Pharmaceuticals' prospects in the healthcare sector, driving increased buying interest during the trading session.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10